Related Experiment Video
Updated: Feb 15, 2026

Nucleoside Triphosphates - From Synthesis to Biochemical Characterization
Published on: April 3, 2014
Biochemical characterization, stability, and pathogen safety of a new fibrinogen concentrate (fibryga®)
Petra M Schulz1, Werner Gehringer1, Sabine Nöhring2
1Octapharma Pharmazeutika Produktionsgesellschaft mbH, R&D Plasma Vienna, Oberlaaerstraße 235, 1100 Vienna, Austria.
Abstract:
Fibryga® is a new lyophilized fibrinogen concentrate for intravenous use for the treatment of congenital fibrinogen deficiency. fibryga® is produced from pooled human plasma and the final product is characterized by high purity, integrity, and pathogen safety. Functional activity of fibrinogen was demonstrated by cross-linking studies and thromboelastometry; integrity of the fibrinogen molecule was demonstrated by size exclusion chromatography and the detection of only trace amounts of activation markers in the final product. Pathogen safety of fibryga® was proved by downscaling studies for the two dedicated pathogen inactivation/removal steps, i.e. solvent detergent treatment and nanofiltration. Fibryga® is stable for at least three years when stored at room temperature. In conclusion, the performed studies demonstrated that fibryga® meets the requirements for a state-of-the-art fibrinogen concentrate, such as a satisfactory activity profile combined with a favorable pathogen safety profile and stability.
Related Concept Videos
Survey Safety
Nuclear Stability
To hold positively charged protons together...
RNA Stability
Concentration Cells
Consider the following voltaic cell:
Stability
The stability of an LTI system is determined by the roots of its characteristic equation, known as poles. A system is stable if it produces a bounded...
Household Wiring And Electrical Safety

